Meisner Lara

Chief Legal OfficerViridian Therapeutics, Inc.\DE (VRDN) · full profile →Form 4 · filed Jun 6, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$186K
Net Open-Market Flow
-$186K
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 6, 2023Option exercise(M)5K$18.51$95K35K
Jun 6, 2023Sell(S)5K$25.02$128K30K
Jun 5, 2023Option exercise(M)499$18.51$9K30K
Jun 5, 2023Sell(S)499$25.03$12K30K
Jun 2, 2023Option exercise(M)2K$14.00$26K32K
Jun 2, 2023Sell(S)2K$24.21$45K30K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 6, 2023Option exercise(M)5K$084K
Jun 5, 2023Option exercise(M)499$090K
Jun 2, 2023Option exercise(M)2K$018K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-014615) within minutes of acceptance. Every field above traces to the original document. Verify it directly: